Vasoactive intestinal peptide degradation might influence interleukin-17 expression in cardiac chagasic patients
| dc.creator | Francielle Beltrãopereira | |
| dc.creator | Walderez Ornelas Dutra | |
| dc.creator | Kenneth j. Gollob | |
| dc.creator | Edna Afonso Reis | |
| dc.creator | Ana Laura Grossi de Oliveira | |
| dc.creator | Manoel Otávio da Costa Rocha | |
| dc.creator | Cristiane Alves da Silva Menezes | |
| dc.date.accessioned | 2024-01-10T19:43:19Z | |
| dc.date.accessioned | 2025-09-08T23:58:51Z | |
| dc.date.available | 2024-01-10T19:43:19Z | |
| dc.date.issued | 2018 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.1590/s1678-9946201860057 | |
| dc.identifier.issn | 16789946 | |
| dc.identifier.uri | https://hdl.handle.net/1843/62545 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Revista do Instituto de Medicina Tropical de São Paulo | |
| dc.rights | Acesso Aberto | |
| dc.subject | Chagas disease | |
| dc.subject | Tryptases | |
| dc.subject | Chymases | |
| dc.subject | Vasoactive Intestinal Peptide | |
| dc.subject | Interleukin-17 | |
| dc.subject.other | Chagas disease | |
| dc.subject.other | Tryptases | |
| dc.subject.other | Chymases | |
| dc.subject.other | Vasoactive Intestinal Peptide | |
| dc.subject.other | Interleukin-17 | |
| dc.title | Vasoactive intestinal peptide degradation might influence interleukin-17 expression in cardiac chagasic patients | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 10 | |
| local.citation.issue | e57 | |
| local.citation.spage | 1 | |
| local.citation.volume | 60 | |
| local.description.resumo | The vasoactive intestinal peptide (VIP) expression is lower in cardiac chagasic patients and is related to worse cardiac function. The reduction of VIP in patients with Chagas disease may be a result of its enhanced degradation. To test this hypothesis, the tryptase and chymase expression was evaluated. We also related VIP levels with interleukin-17 (IL 17) expression since VIP may modulate IL-17 production. Plasma levels of chymase were higher in chagasic patients. Conversely, VIP/chymase and VIP/tryptase ratios were lower in chagasic patients when compared to non-infected individuals. Besides, the VIP/chymase ratio was lower in chagasic cardiac patients in comparison with the indeterminate group. A positive correlation between tryptase and chymase levels was observed in chagasic cardiac patients. In relation to IL-17, we observed a higher expression of this cytokine in the cardiac form of the disease than in the indeterminate form. IL-17/VIP ratio was higher in the cardiac form in comparison with non-infected or indeterminate form. These results suggest that the low levels of VIP observed in chagasic patients could be due to an increased production of chymase and/or to the additive effect of the interaction between chymase and tryptase in the cardiac form. Moreover, the decreased VIP expression may contribute to the increase of IL-17 in chagasic cardiac patients. | |
| local.publisher.country | Brasil | |
| local.publisher.department | FAR - DEPARTAMENTO DE ANÁLISES CLÍNICAS E TOXICOLÓGICAS | |
| local.publisher.department | ICB - DEPARTAMENTO DE MORFOLOGIA | |
| local.publisher.department | ICX - DEPARTAMENTO DE ESTATÍSTICA | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.scielo.br/j/rimtsp/a/TgN6rnJcFxkx6gFndWbK6nB/?lang=en |